Reliable access to biologics and vaccines increasingly depends on manufacturing infrastructures designed for flexibility, redundancy and rapid scalability. In a context of volatile demand, evolving ...

eXoZymes Inc. is featured on the cover of the April issue of GEN Biotechnology with a paper introducing the term "exozymes" to clarify the concept of cell-free biomanufacturing, which produces ...